Oligonucleotide Synthesis Market: By Product Type (Reagents, Equipment, Services), Nucleic Acid Type (DNA, RNA) By Applications (Therapeutic, Research, Diagnostic), By End User (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, Academic Research Institutes, ) and Geography    

Purchase Option

$ 4400
$ 6600
$ 8900

Oligonucleotide Synthesis Market size was valued at USD 9.2 billion in 2022 and is poised to grow at a CAGR of 16.6% from 2023-2029. Oligonucleotide synthesis is the chemical process of creating short, single-stranded sequences of nucleic acids (DNA or RNA) called oligonucleotides. These sequences are essential in various life science research, diagnostics, and therapeutic applications. Oligonucleotide Synthesis is synthesis of short fragments of the nucleic acids which have a defined chemical structure. This process of chemical synthesis enables provide a rapid access to the custom-made oligonucleotides. The building blocks are coupled sequentially which further helps in growing the customized oligonucleotide chain. The research report on Oligonucleotide Synthesis Market contains the COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.

Oligonucleotide Synthesis Market Key Developments: 

  • In October 2017, Integrated DNA Technologies has acquired oligonucleotide manufacturing business of GeneWorks Pty Ltd. (GeneWorks) in Australia.

Oligonucleotide Synthesis Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

16.60%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Oligonucleotide Synthesis Market Dynamics

The increase in adoption of advanced technologies are expected to increase the growth of the market. The surge in initial investments in research and development, companies focused on novel technologies are anticipated to fuel the growth of the market. Furthermore, these R&D activities are adding scope for the advent of new products which is likely to enhance the growth of the market, providing opportunities to the manufactures. The increasing government support in developing technologies such as the oligonucleotide synthesis technology and the genomic technologies is enriching the growth of the market. Personalized medicine is playing a vital role, expected to add fuel for the growth of the market. However, the stringent government regulations in approval of oligonucleotide-based therapeutics are expected to hamper the growth of the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Oligonucleotide Synthesis Market Segmentation

By Product Type
  • Reagents
  • Equipment
  • Services
By Application
  • Diagnostics
  • Research
  • Therapeutics
By End-User
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • CROs and CMOs
  • Academic Research Institutes

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive Summary
2. Global Oligonucleotide Synthesis Market Introduction
2.1. Global Oligonucleotide Synthesis Market - Taxonomy
2.2. Global Oligonucleotide Synthesis Market -Definitions
2.2.1. Product Type
2.2.2. Nucleic Acid Type
2.2.3. Application
2.2.4. End User
2.2.5. Region
3. Global Oligonucleotide Synthesis Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Current Trends
3.5. Global Oligonucleotide Synthesis Market Dynamic Factors - Impact Analysis
3.6. Mergers, Acquisitions, and Collaborations
4. Global Oligonucleotide Synthesis Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Oligonucleotide Synthesis Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Reagents
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Equipment
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Services
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Oligonucleotide Synthesis Market, By Nucleic Acid Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. DNA
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. RNA
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Oligonucleotide Synthesis Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. Therapeutic Applications
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Research Applications
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Diagnostic Applications
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Oligonucleotide Synthesis Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. Hospitals
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Pharmaceutical & Biotechnology Companies
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Diagnostic Laboratories
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. CROs and CMOs
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Academic Research Institutes
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. Global Oligonucleotide Synthesis Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia Pacific
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. MEA
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, and Country, 2023 - 2029
10. North America Oligonucleotide Synthesis Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Reagents
10.1.2. Equipment
10.1.3. Services
10.2. Nucleic Acid Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. DNA
10.2.2. RNA
10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Therapeutic Applications
10.3.2. Research Applications
10.3.3. Diagnostic Applications
10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospitals
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Diagnostic Laboratories
10.4.4. CROs and CMOs
10.4.5. Academic Research Institutes
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.5.1. United States
10.5.2. Canada
10.6. North America Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, 2016-2027
10.7. North America Oligonucleotide Synthesis Market Dynamics - Trends
11. Europe Oligonucleotide Synthesis Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Reagents
11.1.2. Equipment
11.1.3. Services
11.2. Nucleic Acid Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. DNA
11.2.2. RNA
11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Therapeutic Applications
11.3.2. Research Applications
11.3.3. Diagnostic Applications
11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospitals
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Diagnostic Laboratories
11.4.4. CROs and CMOs
11.4.5. Academic Research Institutes
11.5. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.5.1. UK
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, 2016-2027
11.7. Europe Oligonucleotide Synthesis Market Dynamics - Trends
12. Asia Pacific Oligonucleotide Synthesis Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Reagents
12.1.2. Equipment
12.1.3. Services
12.2. Nucleic Acid Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. DNA
12.2.2. RNA
12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Therapeutic Applications
12.3.2. Research Applications
12.3.3. Diagnostic Applications
12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospitals
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Diagnostic Laboratories
12.4.4. CROs and CMOs
12.4.5. Academic Research Institutes
12.5. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. ANZ
12.5.4. Japan
12.5.5. Rest of APAC
12.6. Asia Pacific Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, 2016-2027
12.7. Asia Pacific Oligonucleotide Synthesis Market Dynamics - Trends
13. MEA Oligonucleotide Synthesis Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Reagents
13.1.2. Equipment
13.1.3. Services
13.2. Nucleic Acid Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. DNA
13.2.2. RNA
13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Therapeutic Applications
13.3.2. Research Applications
13.3.3. Diagnostic Applications
13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospitals
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Diagnostic Laboratories
13.4.4. CROs and CMOs
13.4.5. Academic Research Institutes
13.5. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of MEA
13.6. MEA Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, 2016-2027
13.7. MEA Oligonucleotide Synthesis Market Dynamics - Trends
14. Latin America Oligonucleotide Synthesis Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Reagents
14.1.2. Equipment
14.1.3. Services
14.2. Nucleic Acid Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. DNA
14.2.2. RNA
14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Therapeutic Applications
14.3.2. Research Applications
14.3.3. Diagnostic Applications
14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Hospitals
14.4.2. Pharmaceutical & Biotechnology Companies
14.4.3. Diagnostic Laboratories
14.4.4. CROs and CMOs
14.4.5. Academic Research Institutes
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Argentina
14.5.4. Rest of LA
14.6. Latin America Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, 2016-2027
14.7. Latin America Oligonucleotide Synthesis Market Dynamics - Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Integrated DNA Technologies, Inc.
15.2.2. GenScript
15.2.3. Eurofins Scientific SE
15.2.4. Bioneer Corporation
15.2.5. Kaneka Corporation (Eurogentec)
15.2.6. Biolegio B.V.
15.2.7. Eton Bioscience, Inc.
15.2.8. IBA GmbH
15.2.9. Quintara Biosciences
15.2.10. LGC Biosearch Technologies
15.2.11. Thermo Fisher Scientific, Inc.
15.2.12. TriLink BioTechnologies, LLC
15.2.13. TAG Copenhagen A/S
15.2.14. PolyGen GmbH
16. Research Methodology
17. Key Assumptions and Acronyms
  • Integrated DNA Technologies, Inc.
  • GenScript
  • Eurofins Scientific SE
  • Bioneer Corporation
  • Kaneka Corporation (Eurogentec)
  • Biolegio B.V.
  • Eton Bioscience, Inc.
  • IBA GmbH
  • Quintara Biosciences
  • LGC Biosearch Technologies
  • Thermo Fisher Scientific, Inc.
  • TriLink BioTechnologies, LLC
  • TAG Copenhagen A/S
  • PolyGen GmbH

Adjacent Markets

Eosinophilia Market
Dyspepsia Market
Disseminated Intravascular Coagulation Market
Alpha Thalassemia Market
Allergic Rhinitis Market
Histamine Analogs Market